Skip to main content
Top
Published in: BMC Geriatrics 1/2020

Open Access 01-12-2020 | Diabetes | Research article

Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: The Mexican Health and Aging Study

Authors: Alberto J. Mimenza-Alvarado, Gilberto A. Jiménez-Castillo, Sara G. Yeverino-Castro, Abel J. Barragán-Berlanga, Mario U. Pérez-Zepeda, J. Alberto Ávila-Funes, Sara G. Aguilar-Navarro

Published in: BMC Geriatrics | Issue 1/2020

Login to get access

Abstract

Background

Cognitive impairment is twice more frequent in elderly with type 2 diabetes mellitus (DM). This study was conducted to determine the association between glycemic control and cognitive performance among community-dwelling elderly persons in Mexico.

Methods

Cross-sectional study conducted in individuals aged 60 years or elderly participating in the 2012 Mexican Health and Aging Study. Type 2 DM participants were classified in 3 groups according to their glycated hemoglobin levels (HbA1c): < 7% (intensive control), 7–7.9% (standard control) or ≥ 8% (poor control), and cognitive performance: low (CCCE ≤44 points), intermediate (44.1–59.52 points), or high (≥59.53 points). Multinomial logistic regression models were constructed to determine this association.

Results

Two hundred sixteen community-dwelling adults aged 60 and older with type 2 diabetes were selected. Subjects in the low cognitive performance group were older (69.7 ± 6.6 vs 65.86 ± 5.18 years, p < .001) and had a lower educational level (2.5 ± 2.6 vs 7.44 ± 4.15 years, p < .000) when compared to the high cognitive performance participants. HbA1c ≥ 8% was associated with having low (Odds Ratio (OR) 3.17, 95% CI 1.17–8.60, p = .024), and intermediate (OR 3.23, 95% CI 1.27–8.20, p = .014) cognitive performance; this trend was not found for HbA1c 7.0–7.9% group.
The multinomial regression analysis showed that the presence of HbA1c ≥ 8% (poor glycemic control) was associated with low (OR 3.17, 95% CI = 1.17–8.60, p = .024), and intermediate (OR 3.23, 95% CI = 1.27–8.20, p = .014) cognitive performance. After adjusting for confounding variables.

Conclusions

Glycemic control with a HbA1c ≥ 8% was associated with worse cognitive performance.
Literature
1.
go back to reference NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.CrossRef NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016;387(10027):1513–30.CrossRef
2.
go back to reference Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, et al. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex. 2018;60:224–32.CrossRef Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, et al. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex. 2018;60:224–32.CrossRef
3.
go back to reference Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–734.CrossRef Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–734.CrossRef
4.
go back to reference Mukadam N, Sommerland A, Huntley J, et al. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob Health. 2019;7:e596–603.CrossRef Mukadam N, Sommerland A, Huntley J, et al. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob Health. 2019;7:e596–603.CrossRef
5.
go back to reference Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes systematic overview of prospective observational studies. Diabetologia. 2005;48:2460–9.CrossRef Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes systematic overview of prospective observational studies. Diabetologia. 2005;48:2460–9.CrossRef
6.
go back to reference Ott A, Stolk RP, van Harskamp F, Pols HA, et al. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53(9):1937–42.CrossRef Ott A, Stolk RP, van Harskamp F, Pols HA, et al. Diabetes mellitus and the risk of dementia: the Rotterdam study. Neurology. 1999;53(9):1937–42.CrossRef
7.
go back to reference Velayudhan L. Risk of developing dementia in people with diabetes and mild cognitive impairment. Br J Psychiatry. 2010;196:36–40.CrossRef Velayudhan L. Risk of developing dementia in people with diabetes and mild cognitive impairment. Br J Psychiatry. 2010;196:36–40.CrossRef
8.
go back to reference Mejía-Arango S, Zúñiga-Gil C. Diabetes mellitus Como factor de riesgo de demencia en la población adulta mayor mexicana. Rev Neurol. 2011;53:397–405.PubMed Mejía-Arango S, Zúñiga-Gil C. Diabetes mellitus Como factor de riesgo de demencia en la población adulta mayor mexicana. Rev Neurol. 2011;53:397–405.PubMed
10.
go back to reference Munshi M. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know. Diabetes Care. 2017;40:461–7.CrossRef Munshi M. Cognitive dysfunction in older adults with diabetes: what a clinician needs to know. Diabetes Care. 2017;40:461–7.CrossRef
11.
go back to reference Kirkman M, Jones-Briscoe N, Clark N, et al. Diabetes in older adults. J Am Geriatr Soc. 2012;60:2342–56.CrossRef Kirkman M, Jones-Briscoe N, Clark N, et al. Diabetes in older adults. J Am Geriatr Soc. 2012;60:2342–56.CrossRef
12.
go back to reference Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–77.CrossRef Launer LJ, Miller ME, Williamson JD, et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol. 2011;10:969–77.CrossRef
13.
go back to reference Wong R, Michaels-Obregon A, Palloni A. Cohort health and aging study (MHAS). Int J Epidemiol. 2017;46:e2.CrossRef Wong R, Michaels-Obregon A, Palloni A. Cohort health and aging study (MHAS). Int J Epidemiol. 2017;46:e2.CrossRef
14.
go back to reference Kumar A, Wong R, Ottenbacher KJ, et al. Prediabetes, undiagnosed diabetes, and diabetes among Mexican adults: findings from the Mexican health and aging study. Ann Epidemiol. 2016;26:163–70.CrossRef Kumar A, Wong R, Ottenbacher KJ, et al. Prediabetes, undiagnosed diabetes, and diabetes among Mexican adults: findings from the Mexican health and aging study. Ann Epidemiol. 2016;26:163–70.CrossRef
16.
go back to reference Strauss SM, Rosedale M, Pesce MA, et al. Point-of-care HbA1c testing with the A1cNow test kit in general practice dental clinics: a pilot study involving its accuracy and practical issues in its use. Point Care. 2014;13:142–7.CrossRef Strauss SM, Rosedale M, Pesce MA, et al. Point-of-care HbA1c testing with the A1cNow test kit in general practice dental clinics: a pilot study involving its accuracy and practical issues in its use. Point Care. 2014;13:142–7.CrossRef
17.
go back to reference Glosser G, Wolfe N, Albert M, et al. Cross-cultural cognitive examination: validation of a dementia screening instrument for Neuroepidemiological research. J Am Geriatr Soc. 1993;41:931–9.CrossRef Glosser G, Wolfe N, Albert M, et al. Cross-cultural cognitive examination: validation of a dementia screening instrument for Neuroepidemiological research. J Am Geriatr Soc. 1993;41:931–9.CrossRef
18.
go back to reference Mejia-Arango S, Wong R, Michaels-Obregón A. Normative and standardized data for cognitive measures in the Mexican health and aging study. Salud Publica Mex. 2015;57:90–6.CrossRef Mejia-Arango S, Wong R, Michaels-Obregón A. Normative and standardized data for cognitive measures in the Mexican health and aging study. Salud Publica Mex. 2015;57:90–6.CrossRef
19.
go back to reference Bahat G, Tufan F, Saka B, et al. Which body mass index (BMI) is better in the elderly for functional status? Arch Gerontol Geriatr. 2012;54:78–81.CrossRef Bahat G, Tufan F, Saka B, et al. Which body mass index (BMI) is better in the elderly for functional status? Arch Gerontol Geriatr. 2012;54:78–81.CrossRef
20.
go back to reference Aguilar-Navarro S, Fuentes-Cantú A, Ávila-Funes J, et al. Validez y confiabilidad del cuestionario del ENASEM Para la depresión en adultos mayores. Salud Publica Mex. 2007;49:256–62.CrossRef Aguilar-Navarro S, Fuentes-Cantú A, Ávila-Funes J, et al. Validez y confiabilidad del cuestionario del ENASEM Para la depresión en adultos mayores. Salud Publica Mex. 2007;49:256–62.CrossRef
21.
go back to reference Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013;1:183–90.CrossRef Exalto LG, Biessels GJ, Karter AJ, et al. Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study. Lancet Diabetes Endocrinol. 2013;1:183–90.CrossRef
22.
go back to reference Rawlings AM, Sharrett AR, Albert MS, et al. The Association of Late-Life Diabetes Status and Hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study. Diabetes Care. 2019;42:1248–54.CrossRef Rawlings AM, Sharrett AR, Albert MS, et al. The Association of Late-Life Diabetes Status and Hyperglycemia with incident mild cognitive impairment and dementia: the ARIC study. Diabetes Care. 2019;42:1248–54.CrossRef
23.
go back to reference Koekkoek PS, Ruis C, Van Den Donk M, et al. Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes - the ADDITION-Netherlands study: a cluster-randomized trial. Neurol Sci. 2012;314:71–7.CrossRef Koekkoek PS, Ruis C, Van Den Donk M, et al. Intensive multifactorial treatment and cognitive functioning in screen-detected type 2 diabetes - the ADDITION-Netherlands study: a cluster-randomized trial. Neurol Sci. 2012;314:71–7.CrossRef
24.
go back to reference De Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the action in diabetes and vascular disease: preterax and diamicron modified release controlled evaluation (ADVANCE) trial. Diabetologia. 2009;52:2328–36.CrossRef De Galan BE, Zoungas S, Chalmers J, et al. Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the action in diabetes and vascular disease: preterax and diamicron modified release controlled evaluation (ADVANCE) trial. Diabetologia. 2009;52:2328–36.CrossRef
25.
go back to reference Tuligenga RH. Intensive glycaemic control and cognitive decline in patients with type 2 diabetes: a meta-analysis. Endocr Connect. 2015;41:R16–24.CrossRef Tuligenga RH. Intensive glycaemic control and cognitive decline in patients with type 2 diabetes: a meta-analysis. Endocr Connect. 2015;41:R16–24.CrossRef
26.
go back to reference Morley JE. Diabetes: the diabetic brain. Nat Rev Endocrinol. 2017;13:570–1.CrossRef Morley JE. Diabetes: the diabetic brain. Nat Rev Endocrinol. 2017;13:570–1.CrossRef
27.
go back to reference Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010;11:61–74.CrossRef Tabit CE, Chung WB, Hamburg NM, et al. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010;11:61–74.CrossRef
28.
29.
go back to reference Wheeler MJ, Dempsey PC, Grace MS, et al. Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health. Alzheimers Dement (N Y). 2017;3:291–300.CrossRef Wheeler MJ, Dempsey PC, Grace MS, et al. Sedentary behavior as a risk factor for cognitive decline? A focus on the influence of glycemic control in brain health. Alzheimers Dement (N Y). 2017;3:291–300.CrossRef
30.
go back to reference Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci. 2015;1353:60–71.CrossRef Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure. Ann N Y Acad Sci. 2015;1353:60–71.CrossRef
31.
go back to reference Schimming C, Luo X, Zhang C, et al. Cognitive performance of older adults in a specialized diabetes clinic. J Diabetes. 2017;9:929–35.CrossRef Schimming C, Luo X, Zhang C, et al. Cognitive performance of older adults in a specialized diabetes clinic. J Diabetes. 2017;9:929–35.CrossRef
32.
go back to reference Lalithambika CV, Arun CS, Saraswathy LA, et al. Cognitive impairment and its association with glycemic control in type 2 diabetes mellitus patients. Indian J Endocr Metab. 2019;23:353–6.CrossRef Lalithambika CV, Arun CS, Saraswathy LA, et al. Cognitive impairment and its association with glycemic control in type 2 diabetes mellitus patients. Indian J Endocr Metab. 2019;23:353–6.CrossRef
33.
go back to reference Zheng F, Yan L, Yang Z, et al. HbA1c, diabetes and cognitive decline: the English longitudinal study of ageing. Diabetologia. 2018;61:839–48.CrossRef Zheng F, Yan L, Yang Z, et al. HbA1c, diabetes and cognitive decline: the English longitudinal study of ageing. Diabetologia. 2018;61:839–48.CrossRef
35.
go back to reference Liu M, Wang J, He Y, et al. Awareness, treatment and control of type 2 diabetes among Chinese elderly and its changing trend for past decade. BMC Public Health. 2016;16:278.CrossRef Liu M, Wang J, He Y, et al. Awareness, treatment and control of type 2 diabetes among Chinese elderly and its changing trend for past decade. BMC Public Health. 2016;16:278.CrossRef
36.
go back to reference Custodio N, Wheelock A, Thumala D, et al. Dementia in Latin America: epidemiological evidence and implications for public policy. Front Aging Neurosci. 2017;9:221.CrossRef Custodio N, Wheelock A, Thumala D, et al. Dementia in Latin America: epidemiological evidence and implications for public policy. Front Aging Neurosci. 2017;9:221.CrossRef
37.
go back to reference Cheng ST. Cognitive reserve and the prevention of dementia: the role of physical and cognitive activities. Curr Psychiatry Rep. 2016;18:85.CrossRef Cheng ST. Cognitive reserve and the prevention of dementia: the role of physical and cognitive activities. Curr Psychiatry Rep. 2016;18:85.CrossRef
38.
go back to reference Khattab M, Khader YS, Al-Khawaldeh A, et al. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complicat. 2010;24:84.CrossRef Khattab M, Khader YS, Al-Khawaldeh A, et al. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complicat. 2010;24:84.CrossRef
Metadata
Title
Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: The Mexican Health and Aging Study
Authors
Alberto J. Mimenza-Alvarado
Gilberto A. Jiménez-Castillo
Sara G. Yeverino-Castro
Abel J. Barragán-Berlanga
Mario U. Pérez-Zepeda
J. Alberto Ávila-Funes
Sara G. Aguilar-Navarro
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2020
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-020-01827-x

Other articles of this Issue 1/2020

BMC Geriatrics 1/2020 Go to the issue